The DCGI has approved the emergency use of the drug 2-deoxy-D-glucose as an adjunct therapy in moderate to severe Covid-19 patients. The INMAS, a lab of DRDO, has developed the drug, in collaboration with Dr. Reddy’s Laboratories, Hyderabad. In this special episode of Khabardar, we prepared a detailed report on the Covid-19 crisis. Watch the full episode.